Valued at $930.0M at its later-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 14 names
- ·Watch Enable Injections: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Enable Injections funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC | $30.0M | ▮ | ▮ |
| Jan 2022 | Later Stage VC | $150.0M | ▮ | ▮ |
| Oct 2018 | Early Stage VC | $30.7M | ▮ | ▮ |
| Aug 2016 | Early Stage VC | $25.0M | ▮ | ▮ |
| Jun 2016 | Early Stage VC | $5.0M | ▮ | ▮ |
| Sep 2014 | Seed Round | $2.0M | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Enable Injections valuation
Enable Injections was valued at $930 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Enable Injections raised?
Enable Injections has raised $342 million across 7 recorded rounds since 2012. The largest was a $5 million early-stage round in Jun 2016; the most recent was a $30 million early-stage round in Dec 2025.
Enable Injections has filed 16 Form Ds with the SEC since 2014, most recently in Feb 2022 ($150 million sold to 22 investors).
How Enable Injections's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Enable Injections, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Enable Injections
- What is Enable Injections worth?
- Enable Injections is valued at $930.0M as of Oct 2026. Valued at $930.0M at its later-stage round, Jan 2026. Nothing has traded since.
- How much has Enable Injections raised?
- Enable Injections has raised $341.7M in total funding across 7 recorded rounds.
- When did Enable Injections last raise?
- Enable Injections last raised in Dec 2025 (Early Stage VC), raising $30.0M.